Related Experiment Videos
Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators.
Marcus Overhaus1, Beverley A Moore, Joel E Barbato
1Department of Medicine/Gastroenterology, University of Pittsburgh, PA 15261, USA.
Summary
Biliverdin treatment protected against sepsis-induced intestinal inflammation and muscle dysfunction in rats. This study highlights biliverdin
Area of Science:
- Biochemistry
- Immunology
- Gastroenterology
Background:
- Heme oxygenase-1 (HO-1) is a key enzyme in inflammation, producing protective molecules like biliverdin.
- Sepsis can lead to severe inflammation and gastrointestinal dysmotility.
Purpose of the Study:
- To investigate the protective effects of biliverdin against sepsis-induced inflammation and intestinal dysmotility.
- To assess biliverdin's impact on gastrointestinal function and inflammatory markers in a rat sepsis model.
Main Methods:
- Sepsis was induced in rats using cecal ligation and puncture (CLP).
- Biliverdin was administered intraperitoneally before, during, and after CLP.
- Gastrointestinal transit, jejunal muscle contractility, and inflammatory gene expression were analyzed.
Main Results:
- Biliverdin treatment preserved gastrointestinal muscle contractility both in vivo and in vitro.
- Neutrophil infiltration into the jejunal muscularis was significantly reduced by biliverdin.
- Biliverdin decreased pro-inflammatory cytokine mRNA (IL-6, MCP-1) and increased anti-inflammatory cytokine mRNA (IL-10) in septic rats.
Conclusions:
- Biliverdin attenuates sepsis-induced intestinal damage by modulating inflammatory pathways.
- Biliverdin treatment improves intestinal function and reduces inflammation during sepsis.
- Biliverdin is a potential therapeutic agent for sepsis-related gastrointestinal complications.